Does INSULIN LISPRO Cause Atrophy? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Atrophy have been filed in association with INSULIN LISPRO (Humalog KwikPen). This represents 0.0% of all adverse event reports for INSULIN LISPRO.
9
Reports of Atrophy with INSULIN LISPRO
0.0%
of all INSULIN LISPRO reports
1
Deaths
4
Hospitalizations
How Dangerous Is Atrophy From INSULIN LISPRO?
Of the 9 reports, 1 (11.1%) resulted in death, 4 (44.4%) required hospitalization, and 2 (22.2%) were considered life-threatening.
Is Atrophy Listed in the Official Label?
Yes, Atrophy is listed as a known adverse reaction in the official FDA drug label for INSULIN LISPRO.
What Other Side Effects Does INSULIN LISPRO Cause?
Blood glucose increased (31,969)
Incorrect dose administered (8,318)
Blood glucose decreased (6,439)
Drug ineffective (5,411)
Visual impairment (4,654)
Underdose (3,156)
Drug dose omission (3,063)
Glycosylated haemoglobin increased (2,482)
Blood glucose abnormal (2,460)
Malaise (2,204)
What Other Drugs Cause Atrophy?
ADALIMUMAB (76)
ETANERCEPT (43)
METHOTREXATE (37)
TRIAMCINOLONE ACETONIDE (36)
METHYLPREDNISOLONE (34)
INTERFERON BETA-1A (33)
ALENDRONATE (32)
SECUKINUMAB (30)
RITUXIMAB (29)
FINGOLIMOD (28)
Which INSULIN LISPRO Alternatives Have Lower Atrophy Risk?
INSULIN LISPRO vs INSULIN LISPRO-AABC
INSULIN LISPRO vs INSULIN NOS
INSULIN LISPRO vs INSULIN PORK\INSULIN PURIFIED PORK
INSULIN LISPRO vs INTERFERON
INSULIN LISPRO vs INTERFERON ALFA-2A